CHO Pharma, Inc. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 0 compared to TWD 138,000 a year ago. Operating loss was TWD 116.268 million compared to TWD 174.423 million a year ago. Net loss was TWD 110.922 million compared to TWD 167.448 million a year ago. Basic loss per share was TWD 0.6 compared to TWD 0.91 a year ago.